BLS Pharmaceuticals Logo

BLS Pharmaceuticals

🇦🇺
BXNDA
AU0000477796

BLS Pharmaceuticals Limited (formerly Bioxyne) is an Australian pharmaceutical company. It develops, manufactures and distributes medicines and active ingredients, focusing on medical cannabis and consumer health products, with operations across several countries.

Next Quarterly Earnings

Friday, August 28, 2026
CW 35
After-Hours
Tomorrow

After-hours — after the market close (typically after 5:30 p.m. CET).

Currently in quiet period until August 28, 2026

Stock Price

Frequently asked questions

When will BLS Pharmaceuticals report its next quarterly earnings?

BLS Pharmaceuticals is scheduled to report its next quarterly earnings on 08/28/2026. After-hours — after the market close (typically after 5:30 p.m. CET).

When did BLS Pharmaceuticals last report quarterly earnings?

BLS Pharmaceuticals last reported quarterly earnings on 7/27/2026 (Q2 2026).

How do I add the BLS Pharmaceuticals earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q2 2026
Estimate:A$0.07
Actual:
Q2 2026
Estimate:
Actual:
Price reaction (1 day):-3.0 %
Price reaction (7 days):-1.2 %

Company Information

Name
BLS Pharmaceuticals
Ticker Symbol
BXNDA
ISIN
AU0000477796
Country
🇦🇺
Australia
Sector